QSAR WORLD
Home | About QSAR World | Strand Life Sciences | Contact Us
Google Custom Search

Datasets

All datasets in the following list have been manually curated and tested by our experts. Click here to read more about the methodology we follow to get datasets in their present form.

Substructure Search: In order to search for matching substructures in QSAR-World datasets click here

To look for more datasets on other websites click here.

 
 
List of QSAR World Datasets
1

Percentage Human Oral Availability

Reference: Goodman & Gilman's The Pharmacological Basis of Therapeutics, 10/e, Ed. by Joel G. Hardman, Lee E. Limbird and Alfred Goodman Gilman, McGraw-Hill, pp. 1917-2023.  Get Data Files

2

Urinary Excretion

Reference: Goodman & Gilman's The Pharmacological Basis of Therapeutics, 10/e, Ed. by Joel G. Hardman, Lee E. Limbird and Alfred Goodman Gilman, McGraw-Hill, pp. 1917-2023.  Get Data Files

3

Percentage Plasma Binding

Reference: Goodman & Gilman's The Pharmacological Basis of Therapeutics, 10/e, Ed. by Joel G. Hardman, Lee E. Limbird and Alfred Goodman Gilman, McGraw-Hill, pp. 1917-2023.  Get Data Files

4

Clearance (ml/min/kg)

Reference: Goodman & Gilman's The Pharmacological Basis of Therapeutics, 10/e, Ed. by Joel G. Hardman, Lee E. Limbird and Alfred Goodman Gilman, McGraw-Hill, pp. 1917-2023.  Get Data Files

5

Volume of Distribution

Reference: Goodman & Gilman's The Pharmacological Basis of Therapeutics, 10/e, Ed. by Joel G. Hardman, Lee E. Limbird and Alfred Goodman Gilman, McGraw-Hill, pp. 1917-2023.  Get Data Files

6

Half-life

Reference: Goodman & Gilman's The Pharmacological Basis of Therapeutics, 10/e, Ed. by Joel G. Hardman, Lee E. Limbird and Alfred Goodman Gilman, McGraw-Hill, pp. 1917-2023.  Get Data Files

7

Peak Time

Reference: Goodman & Gilman's The Pharmacological Basis of Therapeutics, 10/e, Ed. by Joel G. Hardman, Lee E. Limbird and Alfred Goodman Gilman, McGraw-Hill, pp. 1917-2023.  Get Data Files

8

Peak Concentration

Reference: Goodman & Gilman's The Pharmacological Basis of Therapeutics, 10/e, Ed. by Joel G. Hardman, Lee E. Limbird and Alfred Goodman Gilman, McGraw-Hill, pp. 1917-2023.  Get Data Files

9

Prediction of Human Volume of Distribution Values for Neutral and Basic Drugs. 2. Extended Data Set and Leave-Class-Out Statistics

Get Paper  | Get Data Files

10

VLA-4 integrin antagonists

Get All Four Papers  | Get Data Files

11

Prediction of intestinal absorption: comparative assessment of GASTROPLUSTM and IDEATM

Get Paper  |  Get Data Files

12

Rate-limited steps of human oral absorption and QSAR studies

Get Paper  |  Get Data Files

13

ADME evaluation: 2. A computer model for the prediction of intestinal absorption in humans

Get Paper  | Get Data Files

14

Theoretically-derived molecular descriptors important in human intestinal absorption

Get Paper  | Get Data Files

15

Experimental and Computational Screening Models for the Prediction of Intestinal Drug Absorption

Get Paper  |  Get Data Files

16

MDCK (Madin-Darby Canine Kidney) cells: a Tool for Membrane Permeability Screening

Get Paper  | Get Data Files

17

Quantitative Estimation of Drug Absorption in Humans for Passively Transported Compounds on the Basis of Their Physico-chemical Parameters

Get Paper  | Get Data Files

18

Molecular Hashkeys: A Novel Method for Molecular Characterization and Its Application for Predicting Important Pharmaceutical Properties of Molecules

Get Paper  | Get Data Files

19

Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. Prediction of intestinal absorption

Get Paper  | Get Data Files

20

Toward minimalistic modeling of oral drug absorption

Get Paper  | Get Data Files

21

Prediction of Human Intestinal Absorption of Drug Compounds from Molecular Structure

Get Paper  | Get Data Files

22

Polar Molecular Surface Properties Predict the Intestinal Absorption of Drugs in Humans

Get Paper  | Get Data Files

23

Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties

Get Paper   | Get Data Files

24

CODES/Neural Network Model: a Useful Tool for in Silico Prediction of Oral Absorption and Blood-Brain Barrier Permeability of Structurally Diverse Drugs

Get Paper  | Get Data Files

25

Predicting Passive Intestinal Absorption Using A Single Parameter

Get Paper  | Get Data Files

26

Physicochemical High Throughput Screening: Parallel Artificial Membrane Permeation Assay in the Description of Passive Absorption Processes

Get Paper  | Get Data Files

27

Computational Prediction of Oral Drug Absorption Based on Absorption Rate Constants in Humans

Get Paper  | Get Data Files

28

A General Model for Prediction of Caco-2 Cell Permeability

Get Paper  | Get Data Files

29

In silico ADME Modeling 3: Computational Models to Predict Human Intestinal Absorption Using Sphere Exclusion and kNN QSAR Methods

Get Paper  | Get Data Files

30

Drug Liposome Partitioning as a Tool for the Prediction of Human Passive Intestinal Absorption

Get Paper  | Get Data Files

31

In vitro Permeability Across Caco-2 Cells (Colonic) Can Predict in vivo (Small Intestinal) Absorption in Man - Fact or Myth

Get Paper  | Get Data Files

32

Correlating Partitioning and Caco-2 Cell Permeability of Structurally Diverse Small Molecular Weight Compounds

Get Paper  | Get Data Files

33

A Novel Approach for Prediction of Intestinal Absorption of Drugs in Humans based on Hydrogen Bond Descriptors and Structural Similarity

Get Paper  | Get Data Files

34

Functional Role of P-Glycoprotein in Limiting Intestinal Absorption of Drugs: Contribution of Passive Permeability to P-Glycoprotein Mediated Efflux Transport

Get Paper  | Get Data Files

35

hERG binding specificity and binding site structure: evidence from a fragment-based evolutionary computing SAR study

Get Paper  | Get Data Files

36

Development, interpretation and temporal evaluation of a global QSAR of hERG electrophysiology screening data

Get Paper  | Get Data Files

37

An Accurate and Interpretable Bayesian Classification Model for Prediction of hERG Liability

Get Paper  | Get Data Files

38

QT prolongation through hERG K+ channel blockade: Current knowledge and strategies for the early prediction during drug development

Get Paper  | Get Data Files

39

Correlation of Human Jejunal Permeability (in vivo) of Drugs with Experimentally and Theoretically Derived Parameters: A Multivariate Data Analysis Approach

Get Paper  | Get Data Files

40

Prediction of hERG potassium channel affinity by traditional and hologram QSAR methods

Get Paper  | Get Data Files

41

Toward a Pharmacophore for Drugs Inducing the Long QT Syndrome: Insights from a CoMFA Study of hERG K+ Channel Blockers

Get Paper  | Get Data Files

42

Insights for Human Ether-a-Go-Go-Related Gene Potassium Channel Inhibition Using Recursive Partitioning and Kohonen and Sammon Mapping Techniques

Get Paper  | Get Data Files

43

Molecular Properties That Influence the Oral Bioavailability of Drug Candidates

Get Paper  | Get Data Files

44

Quantitative Structure-Activity Relationship Studies on Inhibition of HERG Potassium Channels

Get Paper  | Get Data Files

45

Development and Evaluation of an in silico Model for hERG Binding

Get Paper  | Get Data Files

46

Assessing the Reliability of a QSAR Model's Predictions

Get Paper  | Get Data Files

47

Characterization of HERG potassium channel inhibition using CoMSiA 3D QSAR and homology modeling approaches

Get Paper  | Get Data Files

48

A Mathematical Model for Prediction of Drug Molecule Diffusion Across the Blood-Brain Barrier

Get Paper  | Get Data Files

Have any Questions?
Name:
Email:
Enter your query/comment here
 

    Facilitated by
    Strand Life Sciences Pvt. LtdStrandls Logo